Search the Newsreel

Carter Bankshares Inc (CARE) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Carter Bankshares Inc (CARE), highlighting its current earnings forecast score of 6.50 within the Banking Services industry. It details analyst ratings, target prices, and expected future EPS and revenue figures. The consensus among 5 analysts points to …

Charter Hall Retail REIT (ASX:CQR) FY26 Profit Rises as Refinancing Resets Debt Position

Marten Transport Is Selling Assets But Continues To Trade At 20x Cycle-Average Earnings

Charter Hall Retail REIT (ASX:CQR) Reports FY26 Growth as Convenience Retail Strategy Delivers Portfolio Expansion

Arteris | 10-Q: Quarterly report

This article is a quarterly report (Form 10-Q) filed by Arteris. It provides a formal regulatory update on the company's financial performance and operations for the specified quarter.

Charter Announces Pricing Terms For Debt Exchange Offers

STAMFORD, Conn., Aug. 6, 2026 /PRNewswire/ -- Charter Communications, Inc. (NASDAQ: CHTR) (along with its subsidiaries, "Charter") announced today the pricing terms for the previously announced private offer (the "Pool 1 Offer") by its wholly-owned subsidiaries, Charter Communications Operating, LLC ("CCO"), Charter Communications Operating …

Carter's, Inc. (CRI) stock price, news, quote and history

This article provides a comprehensive overview of Carter's, Inc. (CRI) stock, including its current price, historical performance, key financial statistics, and analyst insights. It details the company's business segments, product offerings, and market presence within the apparel retail sector, alongside comparative data with similar …

Arteris, Inc. (AIP) Stock Price, News, Quote & History

This article provides comprehensive financial data for Arteris, Inc. (AIP), including its stock price, historical performance, key statistics, and analyst ratings. It also offers an overview of the company's semiconductor IP solutions and its market presence. The stock closed at $31.62, up 2.23%, but …

Earnings call transcript: Charter Hall Retail REIT posts steady FY 2026 growth, shares rise

Arteris, Inc. (AIP) Reports Q2 Loss, Tops Revenue Estimates

Arteris, Inc. (AIP) reported a Q2 loss of $0.1 per share, which missed the Zacks Consensus Estimate of a $0.05 loss. However, the company's revenues for the quarter reached $24.13 million, surpassing the consensus estimate by 2.86%. Despite the earnings miss, Arteris shares have …

Arteris Q2 Earnings Call Highlights

Arteris reported record second-quarter results for 2026, with significant growth in revenue, annual contract value plus royalties, and remaining performance obligations, driven by strong demand across multiple sectors including enterprise computing and automotive. The company highlighted key wins in AI infrastructure and an expanded …

Arteris Q2 2026 slides: record revenue, royalties mask profitability gap

Arteris Inc. reported record revenue of $24.1 million and annual contract value plus royalties of $99.5 million for Q2 2026, both exceeding guidance. Despite strong top-line growth driven by demand in AI, data center, and automotive markets, the company posted a wider-than-expected non-GAAP operating …

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris (Nasdaq: AIP) announced record-breaking financial results for Q2 2026, including 46% year-over-year revenue growth to $24.1 million and 44% growth in Annual Contract Value plus royalties to $99.5 million. The company reported strong customer engagement in various markets, with a 21% increase in …

PIMCO discloses 1.89M-share Carter's Inc (CRI) position in Schedule 13G

PIMCO has reported a 5.1% beneficial ownership stake in Carter's Inc. (CRI), totaling 1,890,588 shares of common stock. This disclosure was made in a Schedule 13G filing, indicating PIMCO, as an investment adviser, holds sole voting and dispositive power over these shares for its …

Artesian Resources Keeps Quarterly Dividend at $0.3199 a Share, Payable Aug. 28 to Holders of Record Aug. 17

Artesian Resources Corporation announced that it will maintain its quarterly dividend at $0.3199 per share. The dividend is scheduled to be payable on August 28 to shareholders of record as of August 17. This news follows a previous announcement where Artesian had raised its …

What Carter's (CRI)'s Strong Q2 Rebound And Completed Buybacks Means For Shareholders

Carter's, Inc. reported strong Q2 2026 results with sales of US$615.49 million and net income of US$104.96 million, alongside the completion of a US$97.57 million share repurchase program. Management projects approximately US$750 million in Q3 net sales and 2% to 3% full-year sales growth …

Artesian Resources declares quarterly dividend of $0.3199 By Investing.com

Artesian Resources Corporation (NASDAQ:ARTNA) has announced a regular quarterly dividend of $0.3199 per share for its Class A and Class B common stock. This dividend, which represents an annualized payout of $1.2796 per share, marks the company's 135th consecutive quarterly dividend. Payments are scheduled …

Arteris earnings up next: Can chip IP play sustain AI momentum?

Arteris Inc. is set to report second-quarter results, with analysts expecting a loss of 4 cents per share on revenue of $23.5 million, reflecting significant year-over-year growth. Investors will focus on the acceleration of royalty revenue from automotive and AI design wins, and the …

Artesian Resources Corporation Declares Third Quarter 2026 Common Stock Dividend

Artesian Resources Corporation announced a quarterly dividend of $0.3199 per share for its Class A and Class B common stock. This dividend, payable on August 28, 2026, to shareholders of record by August 17, 2026, marks the company's 135th consecutive quarterly payout. The annualized …

Artesian Resources Marks 135th Consecutive Quarterly Dividend

Artesian Resources (Nasdaq: ARTNA) has declared its 135th consecutive quarterly dividend, amounting to $0.3199 per share for the third quarter of 2026. This dividend, payable on August 28, 2026, to shareholders of record as of August 17, 2026, represents an annualized rate of $1.2796 …

Cartesian Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Cartesian Therapeutics, Inc. announced its financial results for the second quarter and six months ended June 30, 2026. For the second quarter, the company reported a net income of $15.77 million. However, for the six-month period, the company posted a net loss of $23.41 …

Charter (CHTR) Is Up 5.5% After EPS Rises On Buybacks And New Debt Moves – What Changes?

Charter Communications (CHTR) saw its stock rise after reporting Q2 2026 results, with EPS increasing despite slightly lower sales, largely due to its ongoing share buyback program. The company also engaged in new debt market activity, including a shelf registration and exchange offer for …

Understanding The Descartes Systems Group’s (DSGX) Recent Stock Decline Despite Impressive Revenue

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

Standard Chartered: Attractive Exposure To Emerging Markets Despite Higher Loan Loss Provisions

Arteris Appoints Saurabh Sinha as Chief Financial Officer

Arteris, Inc. (Nasdaq: AIP) has announced the appointment of Saurabh Sinha as its new Chief Financial Officer, effective September 8, 2026. Sinha succeeds Nick Hawkins, who is retiring after seven years with the company and will assist with the transition. The company's President and …

Cartesian Therapeutics Q2 2026 earnings: R&D spending rises as Phase 3 advances

Cartesian Therapeutics (NASDAQ: RNAC) reported Q2 2026 revenue of $0, with a diluted EPS of $0.46. The company experienced an increase in R&D spending due to the advancement of its Phase 3 AURORA trial, which widened its operating loss. However, a significant fair-value gain …

Arteris CFO Nick Hawkins Retires After Seven Years With Company

Arteris (Nasdaq: AIP) announced the appointment of Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. He will succeed Nick Hawkins, who is retiring after seven years but will remain as an advisor for a smooth transition. Sinha brings over 25 years of …

Charter Announces Results Of Early Tenders In Debt Exchange Offers And Amendment And Upsize of Debt Exchange Offers

STAMFORD, Conn., Aug. 6, 2026 /PRNewswire/ -- Charter Communications, Inc. (NASDAQ: CHTR) (along with its subsidiaries, "Charter") announced today the early tender results for the previously announced (i) private offer by its wholly-owned subsidiaries, Charter Communications Operating, LLC ("CCO"), Charter Communications Operating Capital Corp. …

Cartesian Therapeutics Reports Q2 2026 Results, Advances Descartes-08 Clinical Trials and WestGene In Vivo Partnership

Cartesian Therapeutics announced significant progress in its clinical trials for Descartes-08, a cell therapy for autoimmune diseases, including the Phase 3 AURORA trial for myasthenia gravis and Phase 2 TRITON trial for myositis, with data expected in Q1 and H1 2027, respectively. The company …

Cartesian Therapeutics reports Q2 2026: $149.3M cash; net income $15.8M; Phase 3 MG data expected 1Q27

Cartesian Therapeutics reported its Q2 2026 financial results, including $149.3 million in cash and a net income of $15.8 million. The company announced that its Phase 3 AURORA trial for Descartes-08 in myasthenia gravis is on track, with data expected in Q1 2027 and …

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Cartesian Therapeutics reported its Q2 2026 financial results, highlighting significant progress in its clinical pipeline and an extended cash runway into 2028. Key advancements include the Phase 3 AURORA trial for myasthenia gravis, a new strategic partnership with WestGene for an in vivo CAR-T …

Cartesian Therapeutics (Nasdaq: RNAC) Q2 earnings boosted by CVR revaluation

Artesian Resources declares Q3 2026 dividend of $0.3199 per share, continuing 135 quarters of payouts.

Artesian Resources Corporation has announced a quarterly dividend of $0.3199 per share for its Class A and B common stock, payable on August 28, 2026, to shareholders of record by August 17, 2026. This dividend, which represents an annualized payout of $1.2796 per share, …

Can Charter Hall Group (ASX:CHC) Justify Its Valuation On Sean McMahon’s Departure?

Descartes Systems Group (NASDAQ:DSGX) Displays Strong Growth and a Bull Flag Technical Setup

Artesian Resources And 2 Other Top Dividend Stocks To Consider